TRAF3 and Miyoshi myopathy: We also verified the therapeutic effects of oridonin using three TRAF3−/− B lymphoma cell lines (27-9, 105-8, and 115-6) derived from B-TRAF3−/− mice [8,26] and three human patient-derived MM cell lines (8226, KMS11, and LP1) containing TRAF3 deletions or mutations (Edwards and Xie, unpublished data).